By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against ...

A paper shows how partnering with the community can lead to more inclusive health care, especially for individuals with ...

An international team of researchers led by Professor Dr. Lucas Schirmer and Professor Dr. Julio Saez-Rodriguez from the ...

The researchers found that fit individuals shared similar risks of death and cardiovascular disease over the course of the ...

University of Sheffield spinout company, Rinri Therapeutics, a company focused on developing new treatments for hearing loss ...

Two open-access reviews by a renowned neonatal immunologist have highlighted the uniqueness of the developing infant immune ...

Hepatocellular carcinoma, a type of liver cancer, is the sixth most common cancer worldwide and the third leading cause of ...

Many of England's pharmacy technicians are forced to endure low pay, poor job satisfaction, bullying, lack of support and ...

Most cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they ...

An international collaboration led by RIKEN researchers has discovered how unusual spherical structures form in the brains of ...

QIMR Berghofer researchers have made a groundbreaking discovery in the largest ever genetic study on cataracts, analyzing the ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...